Outsourcing Outlook

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Poor API quality may often lead to delays in production and a shortage of supply.

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.